42
Participants
Start Date
November 19, 2020
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Artificial Pancreas (AP)
The AP system used in this trial is the Tandem t:slim insulin pump with Control-IQ Technology. This system is FDA approved for use starting at age 14 years.
University of Virginia Center for Diabetes Technology, Charlottesville
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
DexCom, Inc.
INDUSTRY
Tandem Diabetes Care, Inc.
INDUSTRY
University of Virginia
OTHER